Latest Biotech News

Vor Biopharma has dramatically shifted strategy from oncology to autoimmune disorders, securing $175 million in private equity to support this transition. The company licensed global rights to...

The U.S. CDC’s Advisory Committee on Immunization Practices (ACIP) underwent a controversial reconstitution after Health and Human Services Secretary Robert F. Kennedy Jr. dismissed all prior...

Recent breakthroughs in regenerative biology and therapeutic innovation spotlight promising avenues for tissue repair and organoid technology. Researchers identified a dormant gene switch in mice...

Significant leadership and financing maneuvers are reshaping the biopharma landscape. Incyte appointed Bill Meury as CEO, replacing Hervé Hoppenot after 11 years, with hopes to diversify beyond...

Ongoing research continues to unravel cancer biology and develop novel therapeutics. Nagoya University scientists demonstrated that phagocytosis by macrophages of dying cancer cells inadvertently...

Cutting-edge developments in optical and photonic technologies advance multiple biotech applications. EPFL researchers unveiled the first self-illuminating biosensor using inelastic electron...

Multidisciplinary research sheds light on sustainable solutions for agriculture and material reuse. Chinese Academy of Sciences released Africa’s first high-resolution rice distribution map,...

New studies illuminate brain function dynamics and cognitive health. Indiana University researchers linked reduced grip strength in early psychosis patients to disrupted brain network connectivity...

Biotechnological advances target metabolic and cardiovascular disorders. Phase II siRNA candidate zerlasiran demonstrated promising lipoprotein(a) lowering effects, potentially addressing a...

The Advisory Committee on Immunization Practices (ACIP) has voted 5-2 to recommend Merck & Co.'s Enflonsia, a new respiratory syncytial virus (RSV) antibody, for use in infants born during or...

Several biopharma companies have recently secured substantial funding and forged strategic partnerships bolstering oncology drug development. Revolution Medicines received a flexible $2 billion...

Recent efforts by leading AI developers are markedly advancing biological and pharmaceutical research. DeepMind unveiled AlphaGenome, an AI model predicting gene regulation effects from DNA...

Multiple recent studies have unveiled new insights into cellular and molecular mechanisms underpinning health and disease. Scientists identified a novel organelle, the 'hemifusome,' acting as an...

Notable advances have been reported in therapies for neurological and orphan diseases. Biogen shared encouraging early Phase 1 data for salanersen, an antisense oligonucleotide aimed at spinal...

Progress toward more efficient and precise manufacturing and diagnostic practices continues. Beckman Coulter and Cytiva experts discussed innovations improving monoclonal antibody production via...

Vaccine oversight and policy have entered a period of significant transition. The FDA and NIH issued a consensus glossary to harmonize real-world evidence terminology, aiming for consistency...

Researchers worldwide have made pivotal advances in environmental biotechnology. KAIST chemists developed a breakthrough chemical recycling method converting waste tires into high-purity raw...

Emerging research sheds light on mechanisms and interventions in neurodegenerative diseases. Parse Biosciences and Mount Sinai partnered on a large-scale single-cell transcriptomic study examining...

Recent breakthroughs in artificial intelligence applications are rapidly transforming genomics and drug development. DeepMind's AlphaGenome utilizes advanced machine learning to predict gene...

The oncology landscape sees pivotal advancements with collaboration and novel therapeutic strategies. Kymera Therapeutics secured a $750 million deal with Gilead to develop molecular glue...